Search the Newsreel

Symbotic (NASDAQ: SYM) posts Q3 profit with $22.5B backlog

[10-Q] Symbotic Inc. Quarterly Earnings Report

Symbotic (SYM) Earnings Date and Reports 2026 $SYM

Symbotic (SYM) Is Up 8.3% After Earnings Highlight Software-Led Revenue Mix Shift - What's Changed

Symbotic (SYM) saw an 8.3% increase in its stock price after reporting strong quarterly earnings of US$0.12 per share and US$714.76 million in revenue, driven by broad-based growth and an expanding software maintenance and support segment. This performance aligns with the company's investment thesis …

(AKO.A) Movement as an Input in Quant Signal Sets

This article analyzes Embotelladora Andina S.a. (AKO.A) using AI models to generate trading strategies. It highlights a strong near-term sentiment, transitioning to mid-term neutrality and long-term positive bias, with a significant risk-reward short setup. The analysis provides specific entry, target, and stop-loss levels for …

Symbotic (SYM) sube un 8,3 % tras unos resultados que ponen de relieve un cambio en la composición de los ingresos impulsado por el software: ¿qué ha cambiado?

Microbot Medical (MBOT) Expected to Announce Quarterly Earnings on Tuesday

Microbot Medical (MBOT) is anticipated to report its Q2 2026 earnings before the market opens on Tuesday, August 11th. Analysts project a loss of $0.08 per share on revenue of $0.333 million, with an investor call scheduled for August 13th. The company's previous quarter …

(AKO.B) Volatility Zones as Tactical Triggers

This article analyzes Embotelladora Andina S.a. (AKO.B) using AI models to identify volatility zones and tactical triggers for trading. It presents three distinct trading strategies (Position Trading, Momentum Breakout, and Risk Hedging) tailored to different risk profiles, along with multi-timeframe signal analysis, showing strong …

Microbot Medical Market Sentiment

This article analyzes the market sentiment for Microbot Medical (MBOT), detailing analyst consensus, short interest, options flow, and recent analyst actions. It highlights a "Buy" consensus from four analysts with an average price target of $7, and notes a declining short interest at 11.0%. …

Enterprise value to EBIT forward de Embotelladora Andina SA Pfd A – BCS:ANDINA_A

This page from TradingView provides financial information for Embotelladora Andina SA Pfd A (ANDINA_A) on the Santiago Stock Exchange. It specifically highlights the "Enterprise value to EBIT forward" metric for the company, although no specific data values are present in the provided content. The …

Embotelladora Andina S.A. Stock 12‑Month Price Target Raised to $32.36, Implies 43% Upside

Embotelladora Andina S.A. (ANDINA_A) has seen its average 12-month price target raised to $32.36 by 11 analysts, up from $31.54, with individual forecasts ranging from $30.5 to $36 per share. This new target implies a potential upside of approximately 43% from its July 30th …

Embotelladora Andina SA Pfd A Revenue Breakdown – BCS:ANDINA_A

Embotelladora Andina SA Pfd A (BCS:ANDINA_A) reported total revenue of 3.34 trillion CLP last year, primarily from its Soft Drinks, Other Beverages and Packaging segment. This represents an increase from 3.22 trillion CLP in the prior year. Chile was the largest contributor to revenue, …

Symbotic Gears Up to Report Q3 Earnings: Here's What to Expect

Embotelladora Andina Delivers Strong Q2 2026 Results and Advances Digital, ESG Strategy

Embotelladora Andina announced strong Q2 2026 results, with consolidated sales volume up 3.0%, net sales climbing 11.1%, and adjusted EBITDA growing 17.0%. The company reported broad-based growth across Chile, Brazil, and Paraguay, while also making significant progress in its digital transformation and ESG initiatives. …

Embotelladora Andina distribuye dividendo provisorio

Embotelladora Andina S.A. announced a provisional dividend distribution of $51.0 per Series A share and $56.1 per Series B share, as authorized by a shareholders' meeting in April. This dividend, sourced from 2026 earnings, will be paid to shareholders starting August 27th, with the …

Embotelladora Andina Declares Interim Dividend for 2026 Fiscal Year

COC231 Bond Coupon Profile — Rate & Payments

This article provides a coupon profile for the COC231 bond issued by Embotelladora Andina S.A. It details the bond's interest rate, which is currently 2.72%, and mentions that the next payment is scheduled for September 21, 2026. The piece also highlights the availability of …

Embotelladora Andina (NYSE: AKO-A) sets August 27 interim dividend

Embotelladora Andina (NYSE: AKO-A) announced that its Board of Directors has approved an interim dividend on account of income from the 2026 fiscal year. This dividend, previously authorized by shareholders in April 2026, will be available to shareholders starting August 27, 2026. The Shareholders' …

Embotelladora Andina declares interim dividend of Ch$ 51 per Series A share, Ch$ 56.1 per Series B share

Embotelladora Andina has declared an interim dividend for fiscal year 2026, with Ch$ 51 per Series A share and Ch$ 56.1 per Series B share. The dividend is payable on August 27, 2026, and the shareholders' registry will close on the fifth business day …

Embotelladora Andina Number of Employees 2026 | Employee Count & Headcount Data

As of March 2026, Embotelladora Andina SA has approximately 14,158 total employees worldwide, a 0.3% decline since 2023. The company, headquartered in Santiago, Chile, is actively hiring with 151 job postings in 2026, a 63.8% increase from 2025. South America accounts for 95.5% of …

Microbot Medical Inc (MBOT) Institutional Confidence

Microbot Medical Inc (MBOT) has an institutional shareholding score of 3.00, placing it 192nd out of 385 in the Biotechnology & Medical Research industry. Institutional shareholding proportion increased by 41.23% quarter-over-quarter to 23.09%. Key institutional shareholders include CIBC Private Wealth Advisors, Inc., Susquehanna International …

Symbotic SVP, commercial Alexander sells $367,953 in stock By Investing.com

Alexander Brian Daniel, SVP of Commercial at Symbotic Inc., sold 9,130 shares of company stock for approximately $367,953 on July 24, 2026. This "sell to cover" transaction was mandatory to satisfy tax obligations related to restricted stock unit vesting and is not considered a …

Microbot Medical Inc (MBOT) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of Microbot Medical Inc (MBOT), detailing its current price momentum score, support and resistance levels, and insights from various technical indicators and moving averages. As of July 28, 2026, MBOT's stock is trading between resistance at $1.93 and …

Symbotic CSO William Boyd III sells over $377,000 of shares By Investing.com

Symbotic's Chief Strategy Officer, William M. Boyd III, sold 9,194 shares of the company's Class A common stock for approximately $377,360 on July 27, 2026. This sale followed his acquisition of the same number of shares through the conversion of restricted stock units. Despite …

Symbotic VP, controller Maria Freve sells $90,394 of stock By Investing.com

Maria G. Freve, VP, Controller and Chief Accounting Officer at Symbotic Inc. (NASDAQ:SYM), sold 2,244 shares of the company’s Class A common stock for $90,394 on July 24, 2026. This "sell to cover" transaction was mandatory to satisfy tax withholding obligations related to the …

Symbotic CTO James Kuffner sells $766,695 in stock By Investing.com

Symbotic Inc.'s CTO, James Kuffner, sold 18,987 shares of Class A Common Stock for approximately $766,695 in a "sell to cover" transaction to fulfill tax obligations from vested restricted stock units. This sale was mandated by the company's equity incentive plans, not a discretionary …

Embotelladora Andina S.A. Revenue Breakdown – NYSE:AKO.A

Embotelladora Andina S.A. (NYSE:AKO.A) generated $3.88 billion USD in revenue last year, with its Soft Drinks, Other Beverages and Packaging segment contributing the most at $3.52 billion USD. The largest regional contribution came from Chile, accounting for $1.39 billion USD. This data indicates the …

Microbot Medical Inc (MBOT) Balance Sheet

This article provides a comprehensive balance sheet overview for Microbot Medical Inc (MBOT), detailing its financial health through annual and quarterly data. It covers key financial metrics such as cash and short-term investments, total assets, liabilities, and shareholders' equity, allowing for in-depth fundamental analysis. …

MBOT|Microbot Medical Inc|Price:1.710|Chg%:-0.050

Microbot Medical Inc. (MBOT) is a pre-commercial stage medical technology company focused on developing a single-use, fully disposable endovascular robotic system called LIBERTY. The LIBERTY system is designed for minimally invasive endoluminal surgeries, aiming to simplify complex interventional procedures. As of Q1 2026, 131 …

Embotelladora Andina S.A. Sponsored ADR Pfd Class B Revenue Breakdown – SWB:AKOB

Embotelladora Andina S.A. Sponsored ADR Pfd Class B (SWB:AKOB) generated €3.30 billion in revenue last year, primarily from its Soft Drinks, Other Beverages and Packaging segment, which contributed €2.99 billion. Chile was its largest geographical market, accounting for €1.18 billion in revenue. This revenue …

Microbot Medical Inc. Revenue Breakdown – NASDAQ:MBOT

This article provides a detailed financial overview of Microbot Medical Inc. (NASDAQ: MBOT), focusing on its revenue breakdown. It highlights the company's financial data, including statements, statistics, dividends, earnings, segments, and performance by source and country, all accessible through TradingView.

Microbot Medical Inc (MBOT) Earnings Date & Reports & Earnings News

Microbot Medical (MBOT) Short Interest & Short Float | Updated Jul 2026

Microbot Medical (MBOT) currently has 7.49 million shares sold short as of July 15, 2026, representing 11.71% of its public float, which is a 1.92% increase from the prior report. The short interest ratio stands at 10.9 days to cover, indicating a significant level …

Microbot Medical Inc (MBOT) Valuation: PE, PB & Fair Value Analysis

This article provides a valuation analysis for Microbot Medical Inc (MBOT) as of July 24, 2026. The company's valuation score is 8.19, placing it 164th out of 386 in the Biotechnology & Medical Research industry. Key financial metrics like P/E, P/B, and P/CF ratios …

ETFs Investing in Embotelladora Andina S.A. Sponsored ADR Pfd Class B Stocks

This article lists ETFs that invest in Embotelladora Andina S.A. Sponsored ADR Pfd Class B stocks (AKO.B), highlighting them as a way to access stock market opportunities with lower risk. It provides a structured view of funds holding the stock, including key financial metrics. …

Embotelladora Andina S.A. Revenue Breakdown – NYSE:AKO.B

Embotelladora Andina S.A. (AKO.B) reported total revenue of $3.88 billion USD last year, with its top segment, Soft Drinks, Other Beverages and Packaging, contributing $3.52 billion USD. Chile was the largest geographical contributor, accounting for $1.39 billion USD of the revenue.